12:00 AM
 | 
Jul 21, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Bind Biosciences Inc.

Cambridge, Mass.

Technology: Targeted nanoparticle drug delivery

Disease focus: Cancer, cardiovascular, inflammation

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >